RAPID MICRO BIOSYSTEMS, INC. RPID
Nasdaq · stock · Laboratory Analytical Instruments · website · IPO 2021-07-15
RAPID MICRO BIOSYSTEMS, INC. statistics & valuation
Market cap$84.7M
P / S2.5×
P / B2.6×
Net margin-140.3%
Return on equity-141.9%
FCF margin-95.0%
Net cash$1.1M
Enterprise value USD$83.6M
Earnings yield EBIT/EV-56.7%
Return on capital-84.1%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating margin | -141.1% | -178.0% | -251.2% | -369.0% | -203.3% | -190.0% |
| Net margin | -140.3% | -167.2% | -233.0% | -354.9% | -316.5% | -230.6% |
| FCF margin | -95.0% | -162.3% | -208.4% | -381.1% | -250.4% | -197.1% |
| Return on assets | -63.0% | -47.8% | -36.6% | -31.9% | -30.5% | -53.0% |
| Return on equity | -141.9% | -62.2% | -44.5% | -37.0% | -33.3% | 29.2% |
| Debt / equity | 0.57× | 0.00× | — | 0.00× | 0.00× | -0.20× |
| Current ratio | 3.31 | 4.61 | 6.34 | 7.27 | 12.01 | 4.00 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.